True about low molecular weight heparin except:: (A) Predictable bioavailability, (B) Inhibit factor Ela and Xa, (C) Favorable pharmacokinetics, (D) PT, apt monitoring not required.
Answer is B. Ans. B. Inhibit factor IIa and XaLow molecular weight is sensitive to factor Xa. It has better bioavailability. Its response is predictable therefore monitoring of PT is not required. Example are- dalteparin, enoxaparin.